Skip to main content
Equibles

Odyssean, LLC

Position in RNA — Atrium Therapeutics, Inc.

CIK 2092853 DARIEN, CT
Back to RNA Full portfolio

Position in RNA

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$285,583
New position
Shares Held
21,233
first reported quarter
Ownership
0.124%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#72
of 154 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority Sole 100% Shared 0% None 0%

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Odyssean, LLC holds $61,627,104 across 27 Biotechnology names. RNA ranks #24 (0.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RARE
Ultragenyx Pharmaceutical Inc.
 122,087 $4,076,484
2 KYMR
Kymera Therapeutics, Inc.
 34,485 $3,954,394
3 IDYA
IDEAYA Biosciences, Inc.
 102,582 $3,823,231
4 PCVX
Vaxcyte, Inc.
 62,638 $3,641,146
5 CLDX
Celldex Therapeutics, Inc.
 95,069 $3,537,517
6 MIRM
Mirum Pharmaceuticals, Inc.
 29,924 $3,503,202
7 KRYS
Krystal Biotech, Inc.
 9,349 $3,474,742
8 DNLI
Denali Therapeutics Inc.
 125,062 $3,216,594

All Filings in RNA

Export CSV
1 filing row on record
Report Date Value (USD) Shares
2026-06-30 $285,583 21,233